Akero Therapeutics, Inc.
US ˙ NasdaqGS ˙ US00973Y1082
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityAKRO / Akero Therapeutics, Inc.
InstitutionCaption Management, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Caption Management, LLC ownership in AKRO / Akero Therapeutics, Inc.

On February 17, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 0 shares of Akero Therapeutics, Inc. (US:AKRO) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 39,500 shares of Akero Therapeutics, Inc.. The current value of the position is $0 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (AKRO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AKRO / Akero Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F AKERO THERAPEUTICS COM 00973Y108 0 -100.00 0
2025-11-14 2025-09-30 13F AKERO THERAPEUTICS COM 00973Y108 39,500 8,162 26.05 1,875 12.14 0.0146
2025-08-14 2025-06-30 13F AKERO THERAPEUTICS COM 00973Y108 31,338 26,738 581.26 1,672 798.92 0.0185
2025-05-15 2025-03-31 13F AKERO THERAPEUTICS COM 00973Y108 4,600 4,600 186 0.0018
2025-02-14 2024-12-31 13F AKERO THERAPEUTICS COM 00973Y108 0 -10,087 -100.00 0 -100.00
2024-11-14 2024-09-30 13F AKERO THERAPEUTICS COM 00973Y108 10,087 10,087 289 0.0046
2024-08-14 2024-06-30 13F AKERO THERAPEUTICS COM 00973Y108 0 -10,269 -100.00 0 -100.00
2024-05-15 2024-03-31 13F AKERO THERAPEUTICS COM 00973Y108 10,269 9,738 1,833.90 259 2,058.33 0.0039
2024-02-14 2023-12-31 13F AKERO THERAPEUTICS COM 00973Y108 531 -734 -58.02 12 -80.95 0.0002
2023-11-14 2023-09-30 13F AKERO THERAPEUTICS COM 00973Y108 1,265 -10,835 -89.55 64 -88.83 0.0010
2023-08-14 2023-06-30 13F AKERO THERAPEUTICS COM 00973Y108 12,100 -10,060 -45.40 565 -33.41 0.0100
2023-05-15 2023-03-31 13F AKERO THERAPEUTICS COM 00973Y108 22,160 17,060 334.51 848 203.58 0.0164
2023-02-14 2022-12-31 13F AKERO THERAPEUTICS COM 00973Y108 5,100 5,100 279 0.0044
2020-08-14 2020-06-30 13F AKERO THERAPEUTICS COM 00973Y108 0 -900 -100.00 0 -100.00
2020-05-15 2020-03-31 13F AKERO THERAPEUTICS COM 00973Y108 900 900 19 0.0011
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F AKERO THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2025-11-14 2025-09-30 13F AKERO THERAPEUTICS COM Call 30,000 -78.57 1,424 -80.94 n/a n/a n/a
2025-08-14 2025-06-30 13F AKERO THERAPEUTICS COM Call 140,000 169.23 7,470 255.04 n/a n/a n/a
2025-05-15 2025-03-31 13F AKERO THERAPEUTICS COM Call 52,000 2,105 n/a n/a n/a
2024-08-14 2024-06-30 13F AKERO THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F AKERO THERAPEUTICS COM Call 50,000 82.48 1,263 97.65 n/a n/a n/a
2024-02-14 2023-12-31 13F AKERO THERAPEUTICS COM Call 27,400 -86.65 640 -93.85 n/a n/a n/a
2023-11-14 2023-09-30 13F AKERO THERAPEUTICS COM Call 205,300 502.05 10,384 552.26 n/a n/a n/a
2023-08-14 2023-06-30 13F AKERO THERAPEUTICS COM Call 34,100 13.67 1,592 38.80 n/a n/a n/a
2023-05-15 2023-03-31 13F AKERO THERAPEUTICS COM Call 30,000 1,148 n/a n/a n/a
2023-02-14 2022-12-31 13F AKERO THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F AKERO THERAPEUTICS COM Call 106,300 3,620 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F AKERO THERAPEUTICS COM Put 0 -100.00 0 n/a n/a n/a
2025-11-14 2025-09-30 13F AKERO THERAPEUTICS COM Put 130,000 -43.40 6,172 -49.64 n/a n/a n/a
2025-08-14 2025-06-30 13F AKERO THERAPEUTICS COM Put 229,700 460.24 12,257 638.76 n/a n/a n/a
2025-05-15 2025-03-31 13F AKERO THERAPEUTICS COM Put 41,000 1,660 n/a n/a n/a
2025-02-14 2024-12-31 13F AKERO THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F AKERO THERAPEUTICS COM Put 42,500 1,219 n/a n/a n/a
2024-08-14 2024-06-30 13F AKERO THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F AKERO THERAPEUTICS COM Put 296,500 7,490 n/a n/a n/a
2024-02-14 2023-12-31 13F AKERO THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-14 2023-09-30 13F AKERO THERAPEUTICS COM Put 143,000 376.67 7,233 416.57 n/a n/a n/a
2023-08-14 2023-06-30 13F AKERO THERAPEUTICS COM Put 30,000 -50.00 1,401 -39.00 n/a n/a n/a
2023-05-15 2023-03-31 13F AKERO THERAPEUTICS COM Put 60,000 100.00 2,296 39.60 n/a n/a n/a
2023-02-14 2022-12-31 13F AKERO THERAPEUTICS COM Put 30,000 -86.71 1,644 -78.61 n/a n/a n/a
2022-11-14 2022-09-30 13F AKERO THERAPEUTICS COM Put 225,800 7,686 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.